The AIDS Healthcare Foundation has launched a provocative and controversial print ad campaign against the use of Truvada as a daily HIV preventive. The ads begin running in SFGN this week, following their release in California.
AHF has issued a press release defending the 'PrEP Facts' ads, asserting they advance the public good, "educating the public about adherence issues. AHF believes recommendations by both the Centers for Disease Control (CDC) and World Health Organization (WHO) have developed a misguided strategy for the widespread scale up and implementation of the HIV prevention.
“The eight major studies show the scientific data do not support the large-scale use of Truvada as a community-wide public health intervention to prevent transmission of HIV,” said Michael Weinstein, President of AIDS Healthcare Foundation. “Medication adherence is the primary problem: Even in carefully monitored clinical trials, in which people were counseled monthly, had blood samples drawn and were even paid to participate, many study participants simply did NOT take Truvada every day as prescribed. As such, we want the public to know that the government-sanctioned widespread scale up of PrEP appears to be a public health disaster in the making.”
The ads will run in numerous LGBT, mainstream, and alternative papers including Frontiers, South Florida Gay News, Los Angeles Daily News, Miami New Times, and Hotspots.